The breast imaging market is dominated by traditional mammography, digital breast tomosynthesis ("DBT", "3D mammography"), ultrasound, and MRI technologies, each of which has established clinical applications with well-known limitations. Mammography and DBT remain the primary 2D-based screening tools, yet their sensitivity decreases in approximately 50%+ of women with dense breast tissue1, where overlapping structures under breast compression can obscure lesions and tumours. Ultrasound is often used as a su ...